Paper42394854
Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition better than methylphenidate in two rodent behavioral tests.
Bransom L and 4 others. Discov Pharm Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition better than methylphenidate in two rodent behavioral tests. Papers, record 42394854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42394854
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition better than methylphenidate in two rodent behavioral tests.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 41646286 | Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition compared with methylphenidate. | https://conductscience.org/library/papers/41646286 |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28091799 | Prenatal Risk Factors and the Etiology of ADHD-Review of Existing Evidence. | Curr Psychiatry Rep | 2017 | https://conductscience.org/library/papers/28091799 | PubMed |
| 2 | 19621976 | Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. | CNS Drugs | 2009 | https://conductscience.org/library/papers/19621976 | PubMed |
| 3 | 35507283 | New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development. | Curr Top Behav Neurosci | 2022 | https://conductscience.org/library/papers/35507283 | PubMed |
| 4 | 14732906 | Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. | Am J Hum Genet | 2004 | https://conductscience.org/library/papers/14732906 | PubMed |
| 5 | 10648725 | Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. | J Neurosci | 2000 | https://conductscience.org/library/papers/10648725 | PubMed |
| 6 | 19621977 | Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness. | CNS Drugs | 2009 | https://conductscience.org/library/papers/19621977 | PubMed |
| 7 | 38823551 | Dopamine D1 Receptor Agonists Rescue Age-related Decline in Temporal Order Memory. | Neuroscience | 2024 | https://conductscience.org/library/papers/38823551 | PubMed |
| 8 | 5089457 | The control of short-term memory. | Sci Am | 1971 | https://conductscience.org/library/papers/5089457 | PubMed |
| 9 | 17714372 | Effects of methylphenidate on working memory components: influence of measurement. | J Child Psychol Psychiatry | 2007 | https://conductscience.org/library/papers/17714372 | PubMed |
| 10 | 37578525 | Characterization of behavioral changes in T-maze alternation from dopamine D1 agonists with different receptor coupling mechanisms. | Psychopharmacology (Berl) | 2023 | https://conductscience.org/library/papers/37578525 | PubMed |
| 11 | 23022430 | Timing deficits in attention-deficit/hyperactivity disorder (ADHD): evidence from neurocognitive and neuroimaging studies. | Neuropsychologia | 2013 | https://conductscience.org/library/papers/23022430 | PubMed |
| 12 | 21295057 | Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. | Pharmacol Biochem Behav | 2011 | https://conductscience.org/library/papers/21295057 | PubMed |
| 13 | 25680322 | Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder. | J Neurosci Methods | 2015 | https://conductscience.org/library/papers/25680322 | PubMed |
| 14 | 26174222 | Differentiation of forebrain and hippocampal dopamine 1-class receptors, D1R and D5R, in spatial learning and memory. | Hippocampus | 2016 | https://conductscience.org/library/papers/26174222 | PubMed |
| 15 | 25820982 | Dopaminergic modulation of appetitive trace conditioning: the role of D1 receptors in medial prefrontal cortex. | Psychopharmacology (Berl) | 2015 | https://conductscience.org/library/papers/25820982 | PubMed |
| 16 | 15949990 | Attention-deficit/hyperactivity disorder: a selective overview. | Biol Psychiatry | 2005 | https://conductscience.org/library/papers/15949990 | PubMed |
| 17 | 26608309 | Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. | BMJ | 2015 | https://conductscience.org/library/papers/26608309 | PubMed |
| 18 | 24095262 | Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity? | Med Hypotheses | 2013 | https://conductscience.org/library/papers/24095262 | PubMed |
| 19 | 41860544 | Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial. | JAMA Neurol | 2026 | https://conductscience.org/library/papers/41860544 | PubMed |
| 20 | 37063364 | ADHD in children and adolescents: Review of current practice of non-pharmacological and behavioural management. | AIMS Public Health | 2023 | https://conductscience.org/library/papers/37063364 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42394854
GET https://conductscience.org/api/papers/v1/42394854/references?page=2